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in vivo and of increasing its concentration in the target 
tissue, thereby improving efficacy.[1,2] Their capabilities 
as drug delivery systems with site-specific delivery are 
dependent on their physicochemical properties, especially 
particle size, size distribution and surface morphology. 
Recent research has indicated that the physicochemical 
characteristics of nanoparticles play important roles in 
their adhesion to and interaction with the biological cells 
in the targeted tissues. The physicochemical properties 
of the nanoparticles were shown to be affected by 
several formulation and process parameters, such as 
power and duration of sonication energy applied, drug 
and polymer concentration, solvent volume, polymer 
molecular weight, type and concentration of emulsifier, 
removal rate of organic solvents, aqueous-to-organic 
INTRODUCTION
Polymeric nanoparticles are colloidal carrier systems 
that have been extensively investigated in biomedical 
and biotechnological areas, especially in drug delivery 
systems for drug targeting. They could provide a means 
of modifying the distribution of an active substance 
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ABSTRACT 
The aim of this research was to investigate the effect of the duration of ultrasonication energy on the physicochemical 
characteristics of the nano–sized particulate drug delivery systems. For this purpose, meloxicam-loaded vitamin E 
d-a-tocopheryl polyethylene glycol 1000 succinate (TPGS)-emulsified poly (D,L–lactide–co-glycolide) (PLGA) 
nanoparticles were designed by using ultrasonication-solvent evaporation technique and were characterized by 
photon correlation spectroscopy for size and size distribution, scanning electron microscopy for surface morphology 
and laser Doppler anemometry for surface charge. Ultraviolet -spectrophotometer was used to measure the drug 
encapsulation efficiency and to obtain in vitro drug release profile. The results showed that the physicochemical 
properties of the prepared nanoparticles are effectively controlled by the amount of shear stress transferred from 
the energy source to the emulsion, which is strongly correlated to the ultrasonication time.
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phase ratio, and process temperature. Among them, 
sonication parameters, especially sonication time, are 
the most commonly evaluated factors because of their 
direct influence on the particle size.[3,4] The diameter of 
nanoparticles is a crucial parameter determining the extent 
and rate at which they are removed from the circulation 
and their biodistribution. Indeed, particle size also 
affects drug loading and release from the nanoparticulate 
systems.[5,6]
Several reports concerning the manufacture of polymeric 
nanoparticles have been described within the nano 
range using different preparation techniques. The 
solvent evaporation method is one of the fabricating 
techniques for nanoparticles that can produce nano-sized 
particles by using ultrasonication or homogenization 
procedures.  [1,4] Ultrasonication and homogenization 
methods are two variations of the emulsification-solvent 
evaporation method, and between these two procedures, 
ultrasonication is the more effective method for producing 
smaller size nanoparticles. This can be attributed to the 
capability with ultrasonication of applying higher energy 
and shear forces during the manufacturing process that 
strongly break down the emulsion into nanodroplets, 
which form nanoparticles upon solvent evaporation. In 
this process, ultrasonic vibrations are transmitted into 
the emulsion as ultrasonic waves consisting of alternate 
expansions and compressions, such that an extremely 
higher energy is released into the emulsion to break 
down the droplets than is possible with mechanical 
homogenizers. Furthermore, ultrasonic processing is fast 
and highly reproducible when compared to mechanical 
homogenizers.[5,7,8]
The primary goal of this research was to design a 
polymeric nanoparticulate drug delivery system based on 
a biodegradable polymer, PLGA, and to investigate the 
effect of sonication time (3, 6 and 9 minutes [min]) on the 
physicochemical characteristics of the nanoparticles, which 
were prepared by ultrasonication-solvent evaporation 
technique. Meloxicam, which is an enolic acid-type non 
-steroidal anti-inflammatory drug, was used as an ideal 
hydrophobic molecule for incorporation in nanoparticle 
systems prepared with this processing method. In this 
research, vitamin E TPGS, a new water-soluble derivative 
of natural vitamin E, was selected as an emulsifier in the 
formulations due to its several advantages, including its 
bulky structure and large surface area characteristics, which 
make it an excellent emulsifier. Moreover, it provides a 
desired drug release profile and can be easily washed away 
from the nanoparticle surface.[9-11]
MATERIALS AND METHODS
Materials
Meloxicam was chosen as a model drug (Ulkar Chemical. 
Co., İstanbul, Turkey). PLGA with a copolymer ratio of 
D,L – lactide to glycolide of 50:50 (MW: 40.000-75.000 
Da as indicated by the supplier, Sigma-Aldrich Chemical. 
Co., Munich, Germany) was used as a biodegradable 
polymer. Vitamin E TPGS was used as an emulsifier in 
the emulsification process (Eastman Chemical, USA). 
Methylene chloride (Merck Chemical. Co., Darmstadt, 
Germany) and purified water (Milli-Q, Millipore Corp., 
MA, USA) were used as an organic solvent and suspending 
medium, respectively.
Preparation of nanoparticles
PLGA nanoparticle formulations were prepared using 
emulsification by sonication-solvent evaporation method.  [9,10] 
In this technique, 100 mg PLGA and 10 mg meloxicam were 
dissolved in 4 ml methylene chloride at room temperature. 
The aqueous phase was prepared by dissolving vitamin E 
TPGS in 60 ml Milli-Q water. The organic phase was probe-
sonicated (Bandelin Sonopuls HD 2070, Bandelin Elec., 
Germany) with the aqueous phase containing vitamin E 
TPGS continuously at 55 W of energy output (amplitude 
80%), pulse duty 0.7 sec per cycle, in an ice bath for 3, 
6 and 9 min. The organic phase was then removed by 
evaporation, leaving behind a colloidal suspension of PLGA 
nanoparticles in water. Nanoparticles were recovered by 
ultracentrifugation at 30.000 rpm for 1 hour (h) (Optima 
XL-100K Ultracentrifuge, Beckman Coulter Inc., USA) 
and washed with Milli-Q water to remove excess vitamin 
E TPGS. The nanoparticle suspension was then lyophilized 
(Christ Gamma 2-16 LSC, Martin Christ Gef., Germany) 
for 48 h to obtain a dry powder.
Characterization of PLGA nanoparticles
For the determination of the encapsulation efficiency 
of the lyophilized nanoparticles, firstly the percentage 
of entrapped drug (percent drug loading) was estimated. 
A known amount of nanoparticles was dissolved in 
methylene chloride (direct method) and ultrasonicated 
with 40% power output, pulse duty 0.7 sec per cycle 
(Bandelin Sonopuls HD 2070, Bandelin Elec., Germany) 
for 10 min. After eventual dilutions in methylene chloride, 
the entrapped meloxicam concentration was determined by 
UV-visible spectrophotometry (Shimadzu UV-1240, Japan) 
at a wavelength of 342 nm (n = 6). Percent entrapped drug 
(percent drug loading) was calculated from the ratio of the 
amount of the drug in nanoparticles to the amount of the Journal of Young Pharmacists Vol 3 / No 3  173
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nanoparticles and multiplying by 100. Then, the percentage 
of encapsulation efficiency was estimated from the ratio 
of percent actual drug entrapped loading to the percent 
theoretical entrapped drug (drug loading) and multiplying 
by 100.[11,12]
The mean particle size and size distribution (polydispersity 
index, PDI) of the nanoparticles were analyzed by 
photon correlation spectroscopy (PCS). For this analysis, 
nanoparticles were diluted to the appropriate concentration 
with Milli-Q water at room temperature. Each analysis was 
performed at 25oC with an angle of detection of 90°.
Surface charge (zeta potential) of the nanoparticles 
was determined by laser doppler anemometry (LDA). 
For the determination of the electrophoretic mobility, 
nanoparticles were diluted with Milli-Q water and placed 
in the electrophoretic cell.
The PCS and LDA analyses were performed using 
Zetasizer Nano ZS (Malvern Inst. Inc., Malvern, UK). 
Each nanoparticle formulation was analyzed five times 
and mean particle size, PDI and zeta potential were 
calculated; the average of five measurements was used 
for analysis.
The shape and surface characteristics of the nanoparticles 
were observed by scanning electron microscope (SEM) 
(Jeol JSM-840 A, Japan). A known amount of lyophilized 
nanoparticles was dusted onto double-sided carbon tape, 
which was placed on a metallic surface and coated with gold 
using cold sputter coater (Polaran E 5100) to a thickness 
of 400 Å. The observations were performed at 20 kV 
electron beam.
In vitro drug release studies
The in vitro release of meloxicam from vitamin E TPGS 
emulsified PLGA nanoparticles was determined by dialysis 
membrane method[13] in phosphate-buffered saline (PBS) 
pH 7.4.[14] Nanoparticles were suspended in Milli-Q water 
and transferred into dialysis bags with a molecular mass cut-
off of 12.000 Da. The bags were placed in a glass container, 
which was submerged in 100 ml buffer solution and shaken 
in a water bath (Memmert WB-14, Germany) at 100 rpm. 
The amount of meloxicam released at pre-determined time 
intervals was determined spectrophotometrically (Shimadzu 
UV-1240, Japan) at the wavelength of 363 nm (n = 3).
Data analysis
All data were expressed as mean ± standard deviation and 
analyzed by one-way ANOVA followed by the Tukey’s 
post-hoc test with the statistical software package SPSS 
9.0 for Windows. Differences at a P-value less than 0.05 
were considered to be statistically significant and all error 
bars were presented as standard deviations.
RESULTS AND DISCUSSION
Preparation of nanoparticles
In this research, in order to obtain nano-sized particle 
systems, we used ultrasonication technique. Unlike 
mechanical homogenizers that rely on pressure and 
high-velocity motion to shear a fluid into small drops, 
the ultrasonic probes use only low ultrasonic vibrational 
energy for atomization, such that an extremely higher 
energy is released into the emulsion system to form nano-
sized droplets. With an ultrasonic processor, processing 
is significantly faster and highly reproducible due to the 
fact that the energy at the probe tip is high, focused and 
adjustable. The ultrasonication process was found very 
suitable for the fabrication of the nano-sized vitamin-E 
TPGS-emulsified PLGA particles. The production of 
PLGA nanoparticle formulations by ultrasonication-
solvent evaporation technique related to an investigation 
on the effect of the various sonication times on the 
physicochemical characteristics of nanoparticles has been 
studied earlier,[3-5,7] however, the influence of the duration 
of sonication energy on the encapsulation efficiency, 
particle size, size distribution, and release properties of 
the vitamin E TPGS-emulsified PLGA nanoparticles 
has not been reported. In this study, it was also evident 
that vitamin E TPGS was very effective in improving the 
ultrasonication-emulsification process for the preparation 
technique of nanoparticles when it was used as an 
emulsifier in the nanoparticle formulations.
Characterization of nanoparticles
The results of the physicochemical characterization 
of the nanoparticles developed are shown in Table 1. 
The encapsulation efficiency of meloxicam within the 
vitamin E TPGS-emulsified PLGA nanoparticles was 
not very high for all nanoparticle formulations and was 
not affected significantly by the studied durations of 
ultrasonication energy (P > 0.05). The emulsification 
agent used in the nanoparticle formulations is one of the 
important factors that influence the drug encapsulation 
efficiency in the nanoparticles. Our encapsulation 
efficiency results indicated that vitamin E TPGS is a 
good but not very effective emulsifier for providing 
very high drug encapsulation in the nanoparticle 
formulations containing a hydrophobic drug such as 174   Journal of Young Pharmacists Vol 3 / No 3
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meloxicam. It was thought that this result might be an 
effect of the physicochemical properties (e.g. partition 
coefficient, aqueous solubility, molecular weight) 
of the hydrophobic drug used in the nanoparticle 
formulation and the interaction between meloxicam 
and vitamin E TPGS during the emulsification process. 
Similar results were reported by Mu and Feng about 
the encapsulation efficiency of the vitamin E TPGS-
emulsified nanoparticles.[10]
The nanoparticle size and size distribution, which are 
explained with PDI and surface charge, play an important 
role in determining the mechanism and efficiency of 
nanoparticle absorption in the targeted area.[7] PDI 
was an indication of the particle size distribution and 
referred to the log normal distribution width of the 
particle diameter.[11] In order to obtain emulsified systems 
with the ultrasonication process, the addition of energy 
is a fundamental step. To verify the influence of this 
factor on the nanoparticle size and size distribution, 
ultrasonication time was varied as 3, 6 and 9 min. The 
effect of the ultrasonication time on the particle size 
and size distribution of the nanoparticles is shown in 
Table 1. The particle size analysis of the vitamin E 
TPGS-emulsified nanoparticles indicated that an increase 
in the sonication time leads to a significant reduction 
in the nanoparticle size (P < 0.05). The increasing 
duration of sonication increases the energy causing 
droplet breakdown, thereby increasing the shear stress 
and resulting in a decrease in particle size. The basic 
scientific principle governing the size of nanodroplets is 
that the external energy released from the ultrasonication 
process provides shear stresses to the emulsion system, 
which results in the formation of nanodroplets. The 
size of the droplets is correlated with the magnitude of 
shear stresses. Any changes in the processing or material 
parameters that decrease shear stresses will increase 
the nanodroplet size. The most direct influence on the 
shear stresses in the emulsion system is exercised by the 
energy density, which is described by the external energy 
applied per unit to the total volume of the emulsion. 
Increasing the energy density directly increases the shear 
stresses and results in a more efficient droplet breakdown 
and hence a reduction in nanodroplet size.[3] With the 
longest time of ultrasonication (9 min), a higher energy 
was released in the emulsification process, which led to 
a rapid dispersion of the polymeric organic phase as 
nanodroplets with small size.[4] When the PDI results 
were investigated based on variation of the sonication 
time for the formulations prepared, it was observed that 
all the nanoparticles produced with vitamin E TPGS 
showed bimodal size distribution, with the PDIs between 
0.449 and 0.651. Another important factor observed was 
that an increase in sonication time leads to an increase 
in the production of smaller particles with narrower size 
distribution. The emulsification can be considered one 
of the most important steps of the process because an 
insufficient dispersion of phases results in larger particles 
with a wide size distribution. Our results were consistent 
with the reports of the other research groups.[4,5]
Zeta potential is an important parameter for the stability 
of the emulsified systems. Suitable absolute value of 
zeta potential indicates the presence of suitable electric 
charge on the surface of the drug-loaded nanoparticles, 
which can cause strong repellent forces among nano-sized 
particles to prevent aggregation of the nanoparticles in 
the dispersion medium.[9,11] The zeta potential values of 
the nanoparticles indicated that the surface charge was 
not affected significantly by the variation in the sonication 
times investigated P > 0.05), as shown in Table 1. 
Vitamin E TPGS-emulsified PLGA nanoparticles were 
found to be stable in dispersion state, possessing suitable 
absolute values of zeta potential and having negative 
surface charges.
The shape and surface morphology of the prepared 
nanoparticles was investigated using SEM. SEM images 
of the prepared nanoparticles are presented in Figure 1. 
It seemed that vitamin E TPGS-emulsified PLGA 
nanoparticles exhibited very spherical shapes within a wide 
size distribution.
Drug release studies were performed using dialysis 
method. In vitro release profiles of meloxicam from 
vitamin E TPGS-emulsified PLGA nanoparticle 
formulations under in vitro sink conditions are given in 
Figure 2. The dissolution data were evaluated statistically 
Table 1: Influence of sonication time on the physicochemical characteristics of nanoparticles (mean ± S.D.)
Sonication time of 
nanoemulsion (min)
Encapsulation efficiency (%) Particle size (nm) (%) PDI Zeta potential 
(mV)
3 57.30 ± 10.30 474.50 ± 24.09 (71.80) 82.28 ± 11.68 (28.20) 0.651 ± 0.15 –29.90 ± 3.27
6 53.77 ± 4.67 397.20 ± 21.10 (63.70) 72.25 ± 15.37 (36.30) 0.571 ± 0.08 –25.20 ± 4.18
9 50.91 ± 0.49 367.40 ± 26.05 (41.00) 68.40 ± 27.27 (59.00) 0.449 ± 0.06 –20.10 ± 2.54
S.D.: Standard deviation, PDI: Polydispersity indexJournal of Young Pharmacists Vol 3 / No 3  175
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by one-way ANOVA with Tukey’s post-hoc test and 
were found to be significantly different depending on 
the variation in the sonication time for the formulations 
investigated (P < 0.05). Lower meloxicam releases were 
obtained in the nanoparticles prepared with shorter 
sonication time. As the sonication time was increased 
in the emulsification process, the highest energy was 
released to the emulsion, leading to the formation of 
smaller nanodroplets, which was directly related to 
the drug release rate from the nanoparticles. Decreasing 
the sonication time resulted in an increase in the particle 
size and thus led to a decrease in the dissolution rate 
of the drug entrapped in the nanoparticles. From the 
drug release profiles of the meloxicam-loaded vitamin E 
TPGS-emulsified PLGA nanoparticles, it also seemed that 
the drug release exhibited a biphasic profile with an initial 
burst effect followed by a sustained release. This finding 
is in agreement with a report of Zhang and Feng.[9] 
CONCLUSION
In the present research, the influence of the sonication 
time on the physicochemical characteristics of vitamin E 
TPGS-emulsified PLGA nanoparticles was systematically 
assessed. Ultrasonication-solvent evaporation technique 
was successfully applied for the preparation of vitamin E 
TPGS-emulsified PLGA nanoparticles encapsulating 
meloxicam. It was concluded that among the various 
formulation parameters, sonication time played an 
important role in the design of PLGA nanoparticles, and 
the size of the nanoparticles decreased with an increase in 
sonication time. The release rate of the entrapped drug can 
be modified by variation of the sonication time.
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Figure 1: Scanning electron micrographs of vitamin E TPGS- 
emulsified PLGA nanoparticles
Figure 2: Effect of sonication time (3, 6 and 9 min) on drug release profiles 
of vitamin E TPGS-emulsified PLGA nanoparticle formulations over 10 days